MedTrace Logo

Investigation of Early Hormonotherapy Efficacy of Prostate Cancer

NCT00375687 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2006-09-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether early hormonotherapy is effective in the treatment of high risk prostate cancer patients after radical prostatectomy.

Conditions

Interventions

DRUG

Triptorelin

Sponsors & Collaborators

  • Kaunas University of Medicine

    lead OTHER

Principal Investigators

  • Mindaugas Jievaltas, MD, PhD · Urology dep. of Kaunas University of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Completion
2020-01-31

Countries

  • Lithuania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00375687 on ClinicalTrials.gov